An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma
about
sameAs
Canadian clinical practice guidelines for acute and chronic rhinosinusitis.Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and childrenNasal polyps in patients with asthma: prevalence, impact, and management challengesLeukotriene antagonists in nasal polyposis: a meta-analysis and systematic review.Montelukast 10 mg improves nasal function and nasal response to aspirin in ASA-sensitive asthmatics: a controlled study vs placeboAspirin-sensitive asthmaProtection against exercise-induced bronchoconstriction by montelukast in aspirin-sensitive and aspirin-tolerant patients with asthmaIntranasal lysine-aspirin administration decreases polyp volume in patients with aspirin-intolerant asthmaAntileukotrienes in upper airway inflammatory diseasesHypersensitivity to Aspirin and other NSAIDs: Diagnostic Approach in Patients with Chronic Rhinosinusitis.Aspirin sensitivity and chronic rhinosinusitis with polyps: a fatal combination.Chronic rhinosinusitis: therapeutic efficacy of anti-inflammatory and antibiotic approaches.Audit of nasal lysine aspirin therapy in recalcitrant aspirin exacerbated respiratory disease.Airway remodelling in asthma: from benchside to clinical practice.Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI/ENDA(#) and GA2LEN/HANNA*.Targeting cysteinyl leukotrienes in patients with rhinitis, sinusitis and paranasal polyps.Montelukast in allergic rhinitis: a systematic review and meta-analysis.Controversies in the treatment of chronic rhinosinusitis.Role of medical therapy in the management of nasal polyps.Is montelukast indicated for treatment of chronic rhinosinusitis with polyposis?Surgical versus medical interventions in CRS and nasal polyps: comparative evidence between medical and surgical efficacy.Effectiveness of leukotriene receptor antagonism in the postoperative management of chronic rhinosinusitis.International Consensus Statement on Allergy and Rhinology: Rhinosinusitis.The Role of Surgery in Management of Samter's Triad: A Systematic Review.Contemporary management of chronic rhinosinusitis with nasal polyposis in aspirin-exacerbated respiratory disease: an evidence-based review with recommendations.Aspirin-exacerbated respiratory disease and current treatment modalities.Relationship between Asthma and Rhinitis: Epidemiologic, Pathophysiologic, and Therapeutic AspectsExpression of cysLT1 and cysLT2 receptor in chronic hyperplastic eosinophilic sinusitis.Aspirin induces IL-4 production: augmented IL-4 production in aspirin-exacerbated respiratory diseaseAntileukotrienes in rhinosinusitis and nasal polyposis.Role of leukotriene inhibitors in the postoperative management of nasal polyps.Urinary leukotrienes in patients with nasal polyposis.Lack of long-term add-on effect by montelukast in postoperative chronic rhinosinusitis patients with nasal polyps.Biological basis and clinical implications of immunological molecules involved in eosinophilic inflammation in allergic rhinitis, chronic rhinosinusitis, and asthma
P2860
Q21245393-73A87A38-78CB-45BA-9F9F-1BC88E84A308Q24197682-80C41CD5-A11D-4AC7-A5A5-382A0E804FE9Q26752819-0933AF56-8A33-4ABC-B25C-BFB7483A9139Q26995842-F412C0A7-F9D1-4B19-9A44-A11A0F2C257BQ28167430-1D9ABB16-0CF3-491B-B1D3-0507DCB4753CQ28174122-89E562BF-59ED-46BE-8CE0-DDAEDEB70E19Q28193713-DD71143A-DEBF-47FF-BCCA-029B33CE9D8CQ28219441-DD6E254A-9D32-420F-BBD4-4FF947438431Q28267571-6752211D-61FE-416B-A028-E56493F2986AQ30407185-253C2FBC-650B-43FC-9B04-23F1BFD8FDF3Q30464467-86516051-FA26-478B-9F9E-1911BB479401Q30473876-1A3E18B3-25EF-49E2-8DDC-3CC099ACB0DBQ33964973-CE2D1E43-69D5-4A8D-A168-FDDCBF05EC68Q34105688-8C847AD4-7F0D-48C9-B528-8A2D598DFEC9Q34188879-7AD52F43-D97A-40E8-A3E3-365DDA37171BQ35627765-19756199-839F-4991-A1B5-D440B0DECB48Q36609797-2401570E-E311-4478-9834-CFEE35CAB476Q37775622-8A89745F-6B00-41C1-B807-C5FBB896AD44Q37978476-7A231A35-D591-425D-8832-C63D48F96820Q38171384-9BD07451-F353-4236-AB4C-CE82DE256939Q38594062-6DFB9B69-7FE1-4250-87B6-C583D6DA2137Q38719006-754DE04A-D4AC-4911-8B72-E6A9256D3399Q38738551-E7364ABF-3522-41B0-B4E3-37104E34813EQ38806426-39650973-8BF8-4C34-9FEE-94F066ED40CBQ38915358-1C05B514-E477-492D-B2C2-E85535B68B31Q38931124-19B9EFDB-2365-4C49-ABF3-E708B21DC8B9Q40770058-04150295-6049-43D7-A8AD-8D4147D93D5CQ41949327-ACF68AEF-8719-4A7E-BE94-74B610F0CD4AQ42129014-85DAB57D-55BE-44F3-98EC-8FFA70D2DD49Q43061713-3411094F-7377-4AF8-9B04-0FDC0A8ADFD9Q46519007-C0632454-58D9-4741-B1A0-A98DD0170F41Q46624636-4D7CECDA-72AF-4DEB-876A-9B59F0201BDCQ47635740-3FF4FB0E-B87A-4556-BC66-F35E8B8CA7ECQ58158403-161A5A80-0336-48DB-8AB1-FF373ABEF6A5
P2860
An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
An open audit of montelukast, ...... lyposis associated with asthma
@ast
An open audit of montelukast, ...... lyposis associated with asthma
@en
An open audit of montelukast, ...... lyposis associated with asthma
@nl
type
label
An open audit of montelukast, ...... lyposis associated with asthma
@ast
An open audit of montelukast, ...... lyposis associated with asthma
@en
An open audit of montelukast, ...... lyposis associated with asthma
@nl
prefLabel
An open audit of montelukast, ...... lyposis associated with asthma
@ast
An open audit of montelukast, ...... lyposis associated with asthma
@en
An open audit of montelukast, ...... lyposis associated with asthma
@nl
P2093
P2860
P1476
An open audit of montelukast, ...... lyposis associated with asthma
@en
P2093
P2860
P304
P356
10.1046/J.1365-2222.2001.01160.X
P407
P577
2001-09-01T00:00:00Z